𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chlorpromazine protection against interleukin-1 and tumor necrosis factor-mediated activities in vivo

✍ Scribed by Riccardo Bertini; Manuela Mengozzi; Marina Bianchi; Jean D. Sipe; Pietro Ghezzi


Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
437 KB
Volume
13
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Zoledronic acid protects against local a
✍ Petra Herrak; Birgit Görtz; Silvia Hayer; Kurt Redlich; Erika Reiter; Jürg Gasse 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

## Abstract ## Objective Increased osteoclast activity is a key factor in bone loss in rheumatoid arthritis (RA). This suggests that osteoclast‐targeted therapies could effectively prevent skeletal damage in patients with RA. Zoledronic acid (ZA) is one of the most potent agents for blocking osteo

Circulating interleukin-1 and tumor necr
✍ Herbert Tilg; Wolfgang Vogel; Christian J. Wiedermann; Leland Shapiro; Manfred H 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

The proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha are thought to play important roles in the pathophysiology of liver disease. Specific antagonists of these cytokines have been found in recent years. Interleukin-1 receptor antagonist is a specific interleukin-1 antagonist.

Interleukin-1α, tumor necrosis factor-α,
✍ M.D. Lastra; A.E. Aguilar; M.A. Cabañas; R. Hernandez; K. Humanez; R. Pastelin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract Oral treatment of zinc modulates cytokine secretion during the gestation, lactation, and weaning periods. We used a experimental mice model of zinc supplementation during the perinatal stages to study the effects of this ion over the production of interleukin IL‐1α, IL‐12, and tumor nec